1. |
Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res, 2018, 30(1): 1-12.
|
2. |
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl), 2022, 135(5): 584-590.
|
3. |
Biere SS, Maas KW, Cuesta MA, et al. Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg, 2011, 28(1): 29-35.
|
4. |
Schreiber D, Rineer J, Vongtama D, et al. Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol, 2010, 5(2): 244-250.
|
5. |
Yang J, Zhang W, Xiao Z, et al. The impact of postoperative conformal radiotherapy after radical surgery on survival and recurrence in pathologic T3N0M0 esophageal carcinoma: a propensity score-matched analysis. J Thorac Oncol, 2017, 12(7): 1143-1151.
|
6. |
Chen SB, Weng HR, Wang G, et al. The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma. J Cancer Res Clin Oncol, 2016, 142(1): 277-286.
|
7. |
Zhang Z, Xu L, Di X, et al. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma. Ann Palliat Med, 2019, 8(5): 708-716.
|
8. |
Zhang Y, Zhang Y, Peng L, et al. Research progress on the predicting factors and coping strategies for postoperative recurrence of esophageal cancer. Cells, 2022, 12(1): 114.
|
9. |
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 2010, 17(6): 1471-1474.
|
10. |
Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and esophagogastric junction cancers, version 2. 2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 2019, 17(7): 855-883.
|
11. |
Xiao ZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg, 2003, 75(2): 331-336.
|
12. |
Chang X, Chen J, Xiao Z, et al. Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy. Ther Adv Med Oncol, 2021, 13: 17588359211061948.
|
13. |
周鑫鹏, 梅新宇. N1 期胸段食管鳞状细胞癌淋巴结转移规律及预后分析. 中国胸心血管外科临床杂志, 2022, 29(12): 1587-1593.
|
14. |
肖泽芬, 周宗玫, 吕纪马, 等. 胸段食管癌淋巴结转移规律与术后放疗范围的探讨. 中华放射肿瘤学杂志, 2008, 17(6): 427-431.
|
15. |
陈跃军, 邹求益, 朱广, 等. 胸段食管癌淋巴结转移特点的临床研究. 中华胃肠外科杂志, 2013, 16(9): 835-837.
|
16. |
Huang W, Li B, Gong H, et al. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: a report of 1077 cases. Radiother Oncol, 2010, 95(2): 229-233.
|
17. |
Ding X, Zhang J, Li B, et al. A meta-analysis of lymph node metastasis rate for patients with thoracic oesophageal cancer and its implication in delineation of clinical target volume for radiation therapy. Br J Radiol, 2012, 85(1019): e1110-1119.
|
18. |
刘晓, 章文成, 于舒飞, 等. T2-3N0M0 期食管癌 R0 术后失败模式分析—术后放疗潜在价值与意义. 中华放射肿瘤学杂志, 2015, 24(1): 19-24.
|
19. |
宋振焱, 焦言, 李洪升, 等. 食管鳞癌根治术后失败模式分析. 中华肿瘤防治杂志, 2018, 25(2): 126-130.
|
20. |
沈文斌, 高红梅, 祝淑钗, 等. pT3N0M0 期胸段食管鳞癌患者术后失败原因分析及其术后放疗思考. 中华放射肿瘤学杂志, 2017, 26(4): 394-399.
|
21. |
沈文斌, 高红梅, 祝淑钗, 等. T1-4N0-1M0 期胸段食管鳞癌根治性切除术后失败模式对术后辅助治疗的意义. 中华放射医学与防护杂志, 2018, 38(4): 265-272.
|
22. |
李春阳, 余静, 沈九零, 等. 胸段食管鳞癌术后复发模式及淋巴结复发规律. 中华放射肿瘤学杂志, 2019, 28(9): 673-676.
|
23. |
Li CL, Zhang FL, Wang YD, et al. Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer. Oncol Lett, 2013, 5(1): 355-359.
|